Skip to main content
OpenTrials
Completed

NCT Number: NCT00329095

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance

This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

About this study

This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Currently using one or two topical ocular hypotensive medications

Exclusion criteria

  • Hypersensitivity to any component of medication

Treatment and study plan

travoprost, latanoprost, or bimatoprost

Drug

Additional ocular hypotensive medication

Drug

Primary outcomes

  1. Compliance.

Sponsors and collaborators

Lead sponsor

Robin, Alan L., M.D.

Indiv

Registry information

Official study title

An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures

Important dates

Study start
2005
Study completion
2006
First posted
May 24, 2006
Registry last updated
May 24, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.